PreveCeutical(TM) Medical Begins Trading on the OTC Market
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTC Pink: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the quotation of its common shares for trading on the OTC Pink market, under the symbol "PRVCF". In connection with the quotation of its shares on the OTC, the Company is completing its filings for the quotation of its shares on the OTCQB market. The Company has also made an application for its common shares to be...
2017-08-16 3:05 AM EDT
PreveCeutical(TM) Medical Inc. Announces Requisitions to Acquire State-of-the-Art Instrumentation Expediting Suite of Research and Developments Programs
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2017) - PreveCeutical™ Medical Inc. (CSE: PREV) (FSE: 18H) (the "Company" or "PreveCeutical") announces the Company has acquired four new key instruments to assist in expediting PreveCeutical's current pipeline of innovative Research and Development Programs (R&D). PreveCeutical anticipates delivery and commissioning of all four systems in the next four to six weeks. R&D Programs Dual Gene Therapy This program paves the way for...
2017-08-14 3:05 AM EDT